Balaji Amines Q1 FY27: Revenue up 32%, PAT up 81% YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

BALAMINES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.0%Reaction day

₹2298.00

prior close

₹2350.00

announcement price

After-mkt

timing

Nifty Microcap 250market-1.3%-1.7% vs market

Specialty Chemicals peers, median of 95sector-1.1%-1.8% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

-0.3

15m

-1.1

30m

-2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.0-1.3-1.7-1.1-1.8

Next day

-1.7-0.8-0.8-0.6-1.1

-2.8-1.4-1.4-1.8-1.0

-7.4-0.3-7.1-1.3-6.1

-12.2+1.0-13.3-0.1-12.1

-13.1+1.5-14.6+0.0-13.2

-8.7+3.1-11.8+1.2-9.9

15d

-8.4+4.1-12.5+0.5-9.0

+3.7+4.8-1.0+2.8+0.9

-5.7+3.1-8.8+2.7-8.4

-19.3-3.6-15.7-6.0-13.3

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 95Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Balaji Amines Q1 FY27 (ended June 30, 2026): Standalone revenue up about 32% YoY to Rs 422.74 crore; PAT up about 81% to Rs 72.14 crore. EPS at Rs 22.27 vs Rs 12.28. Consolidated revenue up about 27% to Rs 455.93 crore; PAT up about 114% to Rs 78.12 crore. EBITDA margin expanded to around 26% from about 20% YoY. No exceptional items. Auditors M. Anandam and Co issued an unmodified review opinion.

Likely market impact

Strong revenue and profit growth with margin expansion and a clean audit opinion signal solid operating momentum.